Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
BMI of 30 or higher (obesity) BMI of 27 or higher with at least one weight-related condition (hypertension, high cholesterol, sleep apnea, Type 2 diabetes, or cardiovascular disease) Prior difficulty maintaining weight loss through diet and exercise alone No contraindicated medical history (reviewed at consultation) Commitment to regular monitoring and follow-up visits Personal or family history of medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Prior serious hypersensitivity reaction to semaglutide or excipients Current pregnancy or active breastfeeding Certain pancreatic conditions (evaluated at consultation) Not sure if you qualify
The dosages are always the same, and in the case of tirzepatide injections or other weight loss drugs, they come in pre-loaded syringes containing fixed doses
This clearly identifies the medication and demonstrates its prescribed for personal use
Single-pathway GLP-1 receptor agonists are the older, established class
Its a thriving parallel marketplace
